How Big of an Opportunity Do Pfizer and BioNTech Have in Vaccinating Younger Kids?

How Big of an Opportunity Do Pfizer and BioNTech Have in Vaccinating Younger Kids?

Source: 
Motley Fool
snippet: 
  • Pfizer and BioNTech recently announced positive data from a late-stage study in younger kids.
  • The companies plan to soon file for FDA authorization in this younger age group.
  • The market opportunity could be around $1 billion but depends heavily on vaccination rates.